Terug
Dagbereik
€ 2,34
€ 2,34
52-Weeksbereik
€ 2,14
€ 2,88
Volume
300
50D / 200D Gem.
€ 2,26
/
€ 2,31
Vorige Slotkoers
€ 2,34
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 2,0 | 0,4 |
| P/B | 0,2 | 2,9 |
| ROE % | 7,9 | 3,8 |
| Net Margin % | 3,9 | 3,9 |
| Rev Growth 5Y % | 2,3 | 10,0 |
| D/E | 0,6 | 0,2 |
Belangrijkste Punten
Revenue grew 2,25% annually over 5 years — modest growth
Negative free cash flow of -954,41M
P/E of 2,04 — trading at a low valuation
Capital efficient — spends only 1,60% of revenue on capex
ROIC of 3,87% — low return on invested capital
Groei
Revenue Growth (5Y)
2,25%
Revenue (1Y)0,61%
Earnings (1Y)2,49%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
7,89%
ROIC3,87%
Net Margin3,85%
Op. Margin4,01%
Veiligheid
Debt / Equity
0,55
Current Ratio1,57
Interest Coverage7,26
Waardering
P/E Ratio
2,04
P/B Ratio0,16
EV/EBITDA3,87
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,61% | Revenue Growth (3Y) | -0,05% |
| Earnings Growth (1Y) | 2,49% | Earnings Growth (3Y) | -15,35% |
| Revenue Growth (5Y) | 2,25% | Earnings Growth (5Y) | -5,99% |
| Profitability | |||
| Revenue (TTM) | 75,45B | Net Income (TTM) | 2,91B |
| ROE | 7,89% | ROA | 3,44% |
| Gross Margin | 15,18% | Operating Margin | 4,01% |
| Net Margin | 3,85% | Free Cash Flow (TTM) | -954,41M |
| ROIC | 3,87% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,55 | Current Ratio | 1,57 |
| Interest Coverage | 7,26 | Dividend Yield | 0,05% |
| Valuation | |||
| P/E Ratio | 2,04 | P/B Ratio | 0,16 |
| P/S Ratio | 0,08 | PEG Ratio | 1,82 |
| EV/EBITDA | 3,87 | Dividend Yield | 0,05% |
| Market Cap | 5,93B | Enterprise Value | 11,69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 75,45B | 74,99B | 75,52B | 70,79B | 69,01B |
| Net Income | 2,91B | 2,84B | 4,06B | 3,97B | 3,72B |
| EPS (Diluted) | 1,82 | 1,74 | 2,49 | 2,44 | 2,29 |
| Gross Profit | 11,46B | 12,52B | 14,19B | 13,28B | 13,23B |
| Operating Income | 3,02B | 3,60B | 5,12B | 5,07B | 4,79B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 84,55B | 81,68B | 78,59B | 74,67B | 66,12B |
| Total Liabilities | 43,41B | 43,91B | 41,91B | 41,03B | 34,79B |
| Shareholders' Equity | 37,81B | 35,90B | 34,92B | 32,07B | 29,06B |
| Total Debt | 20,70B | 12,37B | 11,70B | 11,43B | 9,92B |
| Cash & Equivalents | 14,95B | 18,27B | 21,31B | 22,50B | 22,38B |
| Current Assets | 61,55B | 57,76B | 55,98B | 57,06B | 52,81B |
| Current Liabilities | 39,14B | 38,92B | 36,24B | 37,40B | 32,25B |